UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
June 14 2019 - 3:00PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in
point-of-care diagnostic tests and specimen collection devices,
today announced that Roberto Cuca, Chief Financial Officer, will
speak to the investment community at the Raymond James Life
Sciences and MedTech Conference. The conference will be
simultaneously webcast over the Internet.
Mr. Cuca is scheduled to speak on Wednesday,
June 19, 2019, at approximately 3:35 PM Eastern Time (12:35 PM
Pacific Time). Interested investors can access the live
webcast of the presentation by going to OraSure Technologies’ web
site, www.orasure.com and clicking on the Investors link. A
replay of the webcast will be available on OraSure Technologies’
web site for seven days. Alternatively, you can access the
live webcast of the presentation via the following link:
http://wsw.com/webcast/rj115/osur/
About OraSure
TechnologiesOraSure Technologies is empowering
the global community to improve health and wellness by providing
access to accurate essential information. OraSure is a leader
in the development, manufacture and distribution of point-of-care
diagnostic tests, molecular collection devices and other
technologies designed to detect or diagnose critical medical
conditions. Its first-to-market, innovative products include rapid
tests for the detection of antibodies to HIV and Hepatitis C (HCV)
on the OraQuick® platform, sample self-collection and stabilization
products for molecular applications, and oral fluid laboratory
tests for detecting various drugs of abuse. Together with its
wholly-owned subsidiaries (DNA Genotek, CoreBiome and Novosanis),
OraSure provides its customers with value-added, end-to-end
solutions that encompass tools, diagnostics and services.
OraSure’s portfolio of products is sold globally to various
clinical laboratories, hospitals, clinics, community-based
organizations and other public health organizations, research
institutions, distributors, government agencies, physicians’
offices, commercial and industrial entities and consumers. For more
information on OraSure Technologies, please visit
www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial Officer |
VP Corporate Communications |
610-882-1820 |
484-353-1575 |
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jun 2024 to Jul 2024
OraSure Technologies (NASDAQ:OSUR)
Historical Stock Chart
From Jul 2023 to Jul 2024